THE WORKING GROUP ON PHARMACEUTICAL SAFETY INC

THE WORKING GROUP ON PHARMACEUTICAL SAFETY INC THE WORKING GROUP ON PHARMACEUTICAL SAFETY WAS CREATED TO ADDRESS SERIOUS GAPS IN CURRENT POLICY THAT HAVE LED TO A DANGEROUS INCREASE IN THE VOLUME OF MASS MANUFACTURED, UNREGULATED PHARMACEUTICAL PRODUCTS CREATED UNDER THE GUISE OF PHARMACY COMPOUNDING IN THE U.S. IN CONSULTATION WITH PATIENT ADVOCATES, PUBLIC HEALTH, MEDICAL, PROFESSIONAL AND PHARMACEUTICAL COMPANIES, THE GROUP IS COMMITTED TO FINDING WORKABLE POLICY SOLUTIONS TO REDUCE PATIENT EXPOSURE TO UNSAFE OR INEFFECTIVE PRODUCTS THAT DO NOT MEET FEDERAL SAFETY, EFFICACY AND QUALITY STANDARDS, AND TO IMPROVE THE OVERALL SAFETY AND SECURITY OF THE NATION'S DRUG SUPPLY.